Drug Shortage Report for KETOROLAC TROMETHAMINE INJECTION USP

Last updated on 2025-08-05 History
Report ID 261967
Drug Identification Number 02239944
Brand name KETOROLAC TROMETHAMINE INJECTION USP
Common or Proper name KETOROLAC TROMETHAMINE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) KETOROLAC TROMETHAMINE
Strength(s) 30MG
Dosage form(s) SOLUTION LIQUID
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 ML
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-07-07
Estimated end date Unknown
Actual end date 2025-08-04
Shortage status Resolved
Updated date 2025-08-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-08-05 English Compare
v5 2025-08-04 French Compare
v4 2025-08-04 English Compare
v3 2025-07-08 English Compare
v2 2025-07-07 French Compare
v1 2025-07-07 English Compare

Showing 1 to 6 of 6